(Vienna, 02, December, 2014) With inflammatory bowel disease (IBD) thought to cost the European Community over €2 billion in annual healthcare costs…

Vienna, 24 November 2014 – United European Gastroenterology (UEG) is supporting the second annual Awareness Week on Alcohol Related Harm (AWARH)

Lugano/Geneva, Switzerland, 24 November 2014 – High-dose interleukin-2 can be effective in selected metastatic renal cell cancer patients pre-treated…

Summary of Presentations from the Novartis-Supported Satellite Symposium, held at the 23rd EADV Congress, Amsterdam, on 9th October 2014

The meeting provided a bench-to-bedside overview of the targeting of interleukin-17 (IL-17) for the treatment of psoriasis.

This article presents an overview of this exciting new technology category, the development of the industry, and future trends in at-home cutaneous…

Quality-switched (q-switched) laser systems are the gold standard for the treatment of benign pigmented lesions and tattoo removal. A frequently used…

Psoriasis is a common inflammatory skin disease and its immuno-aetiopathogenesis has been extensively studied, using both human clinical samples and…

The ‘classical neutrophilic dermatoses’ comprise a spectrum of disorders characterised by rash and neutrophilia. The defining histopathological finding…

The neutrophilic dermatoses (ND) comprise a group of heterogeneous disorders characterised by inflammatory skin lesions that histologically show an…